Try GOLD - Free
Targeted therapies, personalised medicine reshape treatment models
Ingredients South Asia
|September 1-15, 2025
By distribution channel, Retail Pharmacies retained 75% share in 2024; Online Pharmacies are advancing at a 7.30% CAGR to 2030.
By geography, North India captured 33% of the India pharmaceutical market size in 2024; Northeast India is growing the fastest at a 6.40% CAGR through 2030. The global pharmaceutical market size was estimated at US$1,645.75 billion in 2024 and is projected to reach US$2,350.43 billion by 2030, growing at a CAGR of 6.12% from 2025 to 2030. The market is driven by rising chronic disease prevalence, aging populations, and increased healthcare spending.
Key Market Trends & Insights
- North America pharmaceutical market holds a leading position in 2024, accounting for 41.87% of the global share.
- The pharmaceutical market in the U.S. is the largest in North America
- By molecule type, the conventional drugs (small molecules) segment dominated the market with a revenue share of 54.74% in 2024.
- By product, the branded segment dominated the pharmaceutical market with a revenue share of 86.76% in 2024.
- By type, the prescription segment dominated the market with a revenue share of 86.76% in 2024.
Market Size & Forecast
- 2024 Market Size: US$1,645.75 Billion
- 2030 Projected Market Size: US$2,350.43 Billion
- CAGR (2025-2030): 6.12%
- North America: Largest market in 2024
Advancements in biologics, personalised medicine, and RNAi-based therapeutics are enhancing treatment outcomes. Expedited regulatory pathways and growing demand for patient-centric solutions further support market growth. Technological innovations in drug delivery systems and expanding access to healthcare in emerging economies also contribute to market expansion. Strategic collaborations and investments in R&D continue to drive product development and market competitiveness.
This story is from the September 1-15, 2025 edition of Ingredients South Asia.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 9,500+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Ingredients South Asia
Ingredients South Asia
KSMs - Essential building blocks from which APIs synthesised
KEY Starting Materials (KSMs) represent the foundational cornerstones of pharmaceutical manufacturing, serving as the essential building blocks from which Active Pharmaceutical Ingredients (APIs) are synthesised.
5 mins
September 1-15, 2025
Ingredients South Asia
Leader in excipient innovation for controlled-release drugs
EXCIPIENTS, the inactive components in pharmaceutical formulations, play a crucial role in drug delivery, stability, and efficacy.
4 mins
September 1-15, 2025
Ingredients South Asia
Understanding functional foods with nutra ingredients
FOOD products have faced a lot of criticism due to some of the ingredients associated with noncommunicable diseases, effects of some processes leading to losses in some essential nutrients and inclusion of some food additives that people feel may not be healthy.
4 mins
September 1-15, 2025
Ingredients South Asia
Experts call for policy push to boost excipients production
PHARMACEUTICAL experts and industry veterans are sounding the alarm over India's heavy reliance on imported excipients, which are key substances used in drug formulation, highlighting the need for domestic research, advanced technology, and skilled manpower.
4 mins
September 1-15, 2025
Ingredients South Asia
Paras Dairy's Galacia Cheese enters West & South India
PARAS Dairy announced a strategic expansion of its Galacia Cheese portfolio into the Western and Southern markets of India, fuelling its national growth ambition.
1 min
September 1-15, 2025
Ingredients South Asia
Cos embracing innovative strategies to cut eco footprint
IN today's pharma industry, \"sustainable pharmaceuticals\" refer to practices that prioritise minimising environmental impact while promoting public health and social responsibility.
4 mins
September 1-15, 2025
Ingredients South Asia
DoP told to address issues related to fund utilisation in PLI schemes
EXPRESSING concerns over the reduction in budget allocation for the production linked incentive (PLI) schemes in the pharma and medical devices sector, the Parliamentary Panel on Chemicals and Fertilisers has urged the Department of Pharmaceuticals (DOP) to address various issues that impact the implementation of the schemes.
1 min
September 1-15, 2025
Ingredients South Asia
CDMOs allow cos optimise resources, focus on core competencies
THE pharmaceutical industry has undergone significant transformations in recent years, with one of the most notable trends being the rise of Contract Development and Manufacturing Organisations (CDMOs).
4 mins
September 1-15, 2025
Ingredients South Asia
Targeted therapies, personalised medicine reshape treatment models
By distribution channel, Retail Pharmacies retained 75% share in 2024; Online Pharmacies are advancing at a 7.30% CAGR to 2030.
4 mins
September 1-15, 2025
Ingredients South Asia
Phab launches savoury protein bar
PHAB has launched a savoury protein bar - the Bhel Bars, as part of its new Street Collection, making one of the country's most loved snacks portable, proteinpacked, and cleaner than ever before.
1 min
September 1-15, 2025
Listen
Translate
Change font size